Display Settings:

Format

Send to:

Choose Destination
Accession: PRJNA636501 ID: 636501

Identification of 17-DMAG as a novel KDM4B inhibitor for combination therapy

This SuperSeries is composed of the SubSeries listed below. Overall design: Refer to individual Series
AccessionPRJNA636501; GEO: GSE151598
TypeUmbrella project
PublicationsSingh S et al., "17-DMAG dually inhibits Hsp90 and histone lysine demethylases in alveolar rhabdomyosarcoma.", iScience, 2021 Jan 22;24(1):101996
SubmissionRegistration date: 1-Jun-2020
Center for Applied Bioinformatics, St Jude Children's Research Hospital
RelevanceSuperseries
Project Data:
Resource NameNumber
of Links
Sequence data
SRA Experiments21
Publications
PubMed1
PMC1
Other datasets
BioSample21
GEO DataSets3
GEO Data Details
ParameterValue
Data volume, Supplementary Mbytes8422
SRA Data Details
ParameterValue
Data volume, Gbases237
Data volume, Mbytes67343
Identification of 17-DMAG as a novel KDM4B inhibitor for combination therapy encompasses the following 2 sub-projects:
Project TypeNumber of Projects
Epigenomics1
BioProject
accession
OrganismTitle
PRJNA635950Homo sapiensIdentification of 17-DMAG as a novel KDM4B inhibitor for combination therapy [ChIP-seq] (Center for Applied Bioinformatics,...)
Transcriptome or Gene expression1
BioProject
accession
OrganismTitle
PRJNA636180Homo sapiensIdentification of 17-DMAG as a novel KDM4B inhibitor for combination therapy [RNA-seq] (Center for Applied Bioinformatics,...)

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center